V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 180008783 | 180003142 | null | null | null | 2021-03-23 | 2021-03-23 | null | null | null | ALL UKALL2011 CONSOLIDATION A | 100916570 |
| 180008789 | 180003143 | null | null | null | null | 2016-09-22 | Docetaxel + nintedanib | null | null | NOT MATCHED | 100157631 |
| 180008798 | 180003144 | null | null | null | 2017-05-05 | 2017-06-02 | Cyclophosphamide High Dose | null | null | BEVACIZUMAB + IRINOTECAN + TEMOZOLOMIDE | 100334225 |
| 180008844 | 180003146 | null | null | null | null | 2017-10-15 | LENVATINIB | null | null | LENVATINIB | 100576103 |
| 180008856 | 180003147 | null | null | null | null | 2016-05-17 | MITOTANE | null | null | CARBOPLATIN | 101810237 |
| 180008892 | 180003148 | null | null | null | null | 2020-04-24 | Tretinoin | null | null | LENVATINIB | 100126379 |
| 180008897 | 180003149 | null | null | null | null | 2020-04-03 | NB HRNBL-1 Isotretinoin | null | null | PACLITAXEL | 100783167 |
| 180008936 | 180003153 | null | null | null | 2016-08-05 | 2017-08-22 | VANDETANIB | null | null | DINUTUXIMAB BETA | 100233455 |
| 180008988 | 180003156 | null | null | null | null | 2017-12-11 | Carboplatin AUC 2 - 5 | null | null | CAPECITABINE + OXALIPLATIN | 101397408 |
| 180009058 | 180003158 | null | null | null | null | 2018-03-06 | CNS GCT II Germinoma - Ifos Etop | null | null | TRIAL UNSPECIFIED | 100875673 |
| 180009311 | 180003161 | null | null | null | 2019-05-30 | 2019-06-19 | LENVATINIB | null | null | DOCETAXEL | 100085321 |
| 180009363 | 180003164 | null | null | null | 2020-03-20 | 2020-04-01 | WT SIOP 2002 01 pre op VAV | null | null | LENVATINIB | 101285455 |
| 180009418 | 180003167 | null | null | null | 2019-05-14 | 2019-09-30 | NB HRNBL-1 ch14.18/CHO only (trial) | null | null | CISPLATIN + GEMCITABINE | 100460808 |
| 180009453 | 180003168 | null | null | null | null | 2020-06-24 | Trial Unspecified | null | null | CAPECITABINE | 100273419 |
| 180009592 | 180003172 | null | null | null | null | 2019-12-25 | null | null | null | NOT MATCHED | 101816835 |
| 180009623 | 180003173 | null | null | null | null | 2019-07-08 | DABRAFENIB + TRAMETINIB | null | null | FLUOROURACIL + IRINOTECAN | 100674591 |
| 180009685 | 180003174 | null | null | null | 2018-01-09 | 2018-03-05 | NB HRNBL-1 BUMEL MAT | null | null | LENVATINIB | 101809073 |
| 180009719 | 180003176 | null | null | null | 2017-11-14 | 2018-01-11 | CABOZANTINIB | null | null | CYCLOPHOSPHAMIDE + TOPOTECAN | 100657919 |
| 180009955 | 180003183 | null | null | null | null | 2019-11-18 | STREPTOZOCIN | null | null | CARBOPLATIN + LIPOSOMAL DOX | 100887816 |
| 180010054 | 180003190 | 1.1 | null | null | 2022-02-22 | 2022-02-28 | WT SIOP 2002 01 post op Carbo, Etop | null | null | LENVATINIB | 100847966 |
| 180010078 | 180003192 | null | null | null | null | 2019-11-28 | FCarboSt | null | null | SORAFENIB | 101074586 |
| 180010190 | 180003196 | null | null | null | 2021-12-11 | 2022-01-01 | Mitotane + STREPTOZOCIN | null | null | TRABECTEDIN | 100850726 |
| 180010217 | 180003197 | null | null | null | 2021-12-26 | 2022-02-18 | Trial Unspecified | null | null | NOT MATCHED | 100907593 |
| 180010319 | 180003202 | null | null | null | null | 2020-05-22 | MITOTANE | null | null | VANDETANIB | 100947003 |
| 180010514 | 180003212 | null | null | null | 2019-03-08 | 2019-03-08 | null | null | null | AFATINIB | 100308099 |
| 180010519 | 180003213 | null | null | null | 2019-02-24 | 2019-08-27 | ESHAP | null | null | LENVATINIB | 100199719 |
| 180010644 | 180003219 | null | null | null | null | 2016-05-12 | Docetaxel 75mg/m2 (21 day) | null | null | VANDETANIB | 100591380 |
| 180010672 | 180003220 | 0 | null | null | null | 2019-08-28 | LENVATINIB | null | null | PACLITAXEL | 100230100 |
| 180010865 | 180003226 | null | null | null | 2018-04-25 | 2019-06-11 | NB HRNBL-1 TVD | null | null | CISPLATIN + DOXORUBICIN + ETOPOSIDE + MITOTANE | 101414369 |
| 180010875 | 180003227 | null | null | null | null | 2018-10-06 | CARBOPLATIN + PACLITAXEL | null | null | NOT MATCHED | 101719165 |
| 180011112 | 180003232 | null | null | null | null | 2020-08-21 | NB HRNBL-1 ch14.18/CHO only (trial) | null | null | TRIAL UNSPECIFIED | 101208179 |
| 180011121 | 180003233 | null | null | null | null | 2017-07-28 | NB HRNBL-1 Isotretinoin | null | null | FLUOROURACIL + IRINOTECAN | 101829990 |
| 180011222 | 180003236 | null | null | null | null | 2018-12-09 | CAPECITABINE + GEMCITABINE | null | null | VENETOCLAX | 100348590 |
| 180011448 | 180003240 | null | null | null | null | 2018-02-13 | EDP | null | null | LETROZOLE + PALBOCICLIB | 100299274 |
| 180011465 | 180003241 | null | null | null | null | 2016-08-10 | Irinotecan 14day | null | null | LEAM | 101417709 |
| 180011471 | 180003242 | null | null | null | null | 2016-10-03 | null | null | null | NB RELAPSED CYCLOPHOSPHAMIDE AND TOPOTECAN | 101802180 |
| 180011970 | 180003256 | null | null | null | 2019-03-15 | 2019-03-15 | null | null | null | ALL UKALL2011 IND A | 100885217 |
| 180011982 | 180003257 | null | null | null | 2020-04-06 | 2020-06-06 | NB HRNBL-1 Isotretinoin | 01 | null | NB HRNBL-1 CH14.18/CHO ONLY (TRIAL) | 100561714 |
| 180012028 | 180003258 | null | null | null | null | 2017-07-29 | Temozolomide 200mg/m2 | null | null | DINUTUXIMAB BETA | 101510187 |
| 180012155 | 180003268 | null | null | null | 2016-11-13 | 2016-11-21 | Dinutuximab Beta | null | null | NOT MATCHED | 100361650 |
| 180012160 | 180003269 | null | null | null | null | 2020-01-14 | LENVATINIB | null | null | SORAFENIB | 101544286 |
| 180012179 | 180003271 | null | null | null | null | 2020-09-06 | EC | N | null | NB HRNBL-1 CH14.18/CHO(TRIAL) +IL-2 | 100527596 |
| 180012205 | 180003272 | null | null | null | null | 2019-06-11 | Carboplatin + Liposomal Doxorubicin | null | null | CABOZANTINIB | 100400920 |
| 180012307 | 180003274 | null | null | null | null | 2019-04-03 | null | N | null | NB HRNBL-1 CH14.18/CHO ONLY (TRIAL) | 100059119 |
| 180012461 | 180003277 | null | null | null | null | 2017-10-04 | Trifluridine + Tipiracil | null | null | CARBOPLATIN + PEMETREXED | 100898426 |
| 180012541 | 180003280 | null | null | null | 2020-05-14 | 2020-05-18 | NB HRNBL-1 Isotretinoin | null | null | CISPLATIN + DOXORUBICIN + ETOPOSIDE | 101106401 |
| 180012596 | 180003283 | null | null | null | 2017-11-28 | 2017-12-15 | NB HRNBL-1 TVD | null | null | DINUTUXIMAB BETA | 101425806 |
| 180012649 | 180003286 | null | null | null | null | 2018-11-20 | null | null | null | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 101302561 |
| 180012691 | 180003288 | null | null | null | 2019-03-04 | 2019-03-23 | NB Rel CCLG guidelines Cyclo-Topotecan | null | null | DABRAFENIB + TRAMETINIB | 100810944 |
| 180012937 | 180003295 | null | null | null | null | 2016-07-12 | NB Rel CCLG guidelines Irin & Temoz | null | null | TEMOZOLOMIDE | 101273780 |